Cargando…
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series
BACKGROUND: With the advent of innovative therapies including biologics and Janus kinase inhibitors, children with rheumatic diseases are more likely to have improved outcomes. Despite these advances, some children do not respond, or they, or their parents fear adverse events and seek other alternat...
Autores principales: | Wong, Stephen C., Medrano, Leah C., Hoftman, Alice D., Jones, Olcay Y., McCurdy, Deborah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194100/ https://www.ncbi.nlm.nih.gov/pubmed/34112214 http://dx.doi.org/10.1186/s12969-021-00575-5 |
Ejemplares similares
-
Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012) -
Guidance in sepsis management: navigating uncharted waters?
por: Reade, Michael C, et al.
Publicado: (2008) -
Cell Based Treatment of Autoimmune Diseases in Children
por: Jones, Olcay Y., et al.
Publicado: (2022) -
Toxicogenomics research consortium sails into uncharted waters.
por: Medlin, Jennifer
Publicado: (2002) -
Sailing in Uncharted Waters: Carefully Navigating the Polio Endgame
por: Miller, Elizabeth, et al.
Publicado: (2016)